ID   PLD1_HUMAN              Reviewed;        1074 AA.
AC   Q13393;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   15-MAR-2017, entry version 172.
DE   RecName: Full=Phospholipase D1;
DE            Short=PLD 1;
DE            Short=hPLD1;
DE            EC=3.1.4.4;
DE   AltName: Full=Choline phosphatase 1;
DE   AltName: Full=Phosphatidylcholine-hydrolyzing phospholipase D1;
GN   Name=PLD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PLD1A).
RX   PubMed=8530346; DOI=10.1074/jbc.270.50.29640;
RA   Hammond S.M., Altshuller Y.M., Sung T.-C., Rudge S.A., Rose K.,
RA   Engebrecht J., Morris A.J., Frohman M.A.;
RT   "Human ADP-ribosylation factor-activated phosphatidylcholine-specific
RT   phospholipase D defines a new and highly conserved gene family.";
RL   J. Biol. Chem. 270:29640-29643(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PLD1A AND PLD1B).
RX   PubMed=9013646; DOI=10.1074/jbc.272.6.3860;
RA   Hammond S.M., Jenco J.M., Nakashima S., Cadwallader K., Gu Q.-M.,
RA   Cook S., Nozawa Y., Prestwich G.D., Frohman M.A., Morris A.J.;
RT   "Characterization of two alternately spliced forms of phospholipase
RT   D1. Activation of the purified enzymes by phosphatidylinositol 4,5-
RT   bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-
RT   binding proteins and protein kinase C-alpha.";
RL   J. Biol. Chem. 272:3860-3868(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PLD1A; PLD1B AND PLD1C).
RC   TISSUE=Brain, Cervix carcinoma, Chondrocyte, and Skeletal muscle;
RX   PubMed=9761774;
RA   Steed P.M., Clark K.L., Boyar W.C., Lasala D.J.;
RT   "Characterization of human PLD2 and the analysis of PLD isoform splice
RT   variants.";
RL   FASEB J. 12:1309-1317(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PLD1A).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 739-1074 (ISOFORM PLD1D).
RA   Hughes W.E., Parker P.J.;
RT   "A novel human phospholipase D1 splice variant displays conserved
RT   regulation in vitro but altered localisation in vivo.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=9582313; DOI=10.1074/jbc.273.21.12846;
RA   Lopez I., Arnold R.S., Lambeth J.D.;
RT   "Cloning and initial characterization of a human phospholipase D2
RT   (hPLD2). ADP-ribosylation factor regulates hPLD2.";
RL   J. Biol. Chem. 273:12846-12852(1998).
RN   [7]
RP   INTERACTION WITH PIP5K1B.
RX   PubMed=11032811; DOI=10.1093/emboj/19.20.5440;
RA   Divecha N., Roefs M., Halstead J.R., D'Andrea S., Fernandez-Borga M.,
RA   Oomen L., Saqib K.M., Wakelam M.J.O., D'Santos C.;
RT   "Interaction of the type Ialpha PIPkinase with phospholipase D: a role
RT   for the local generation of phosphatidylinositol 4, 5-bisphosphate in
RT   the regulation of PLD2 activity.";
RL   EMBO J. 19:5440-5449(2000).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-629, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-561 AND SER-629, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Implicated as a critical step in numerous cellular
CC       pathways, including signal transduction, membrane trafficking, and
CC       the regulation of mitosis. May be involved in the regulation of
CC       perinuclear intravesicular membrane traffic (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: A phosphatidylcholine + H(2)O = choline + a
CC       phosphatidate.
CC   -!- ENZYME REGULATION: Stimulated by phosphatidylinositol 4,5-
CC       bisphosphate and phosphatidylinositol 3,4,5-trisphosphate,
CC       activated by the phosphokinase C-alpha, by the ADP-ribosylation
CC       factor-1 (ARF-1), and to a lesser extent by GTP-binding proteins:
CC       RHO A, RAC-1 and CDC42. Inhibited by oleate.
CC   -!- SUBUNIT: Interacts with PIP5K1B. {ECO:0000269|PubMed:11032811}.
CC   -!- INTERACTION:
CC       P23528:CFL1; NbExp=4; IntAct=EBI-2827556, EBI-352733;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000250}.
CC       Endoplasmic reticulum membrane {ECO:0000250}; Lipid-anchor
CC       {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Golgi apparatus
CC       membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}; Cytoplasmic
CC       side {ECO:0000250}. Late endosome membrane {ECO:0000250}; Lipid-
CC       anchor {ECO:0000250}; Cytoplasmic side {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=PLD1A;
CC         IsoId=Q13393-1; Sequence=Displayed;
CC       Name=PLD1B;
CC         IsoId=Q13393-2; Sequence=VSP_005020;
CC       Name=PLD1C;
CC         IsoId=Q13393-3; Sequence=VSP_005018, VSP_005019;
CC       Name=PLD1D;
CC         IsoId=Q13393-4; Sequence=VSP_005021, VSP_005022;
CC   -!- TISSUE SPECIFICITY: Expressed abundantly in the pancreas and heart
CC       and at high levels in brain, placenta, spleen, uterus and small
CC       intestine. {ECO:0000269|PubMed:9582313}.
CC   -!- SIMILARITY: Belongs to the phospholipase D family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Phospholipase D entry;
CC       URL="https://en.wikipedia.org/wiki/Phospholipase_D";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PLD1ID43716ch3q26.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U38545; AAB49031.1; -; mRNA.
DR   EMBL; BC068976; AAH68976.1; -; mRNA.
DR   EMBL; AJ276230; CAB76564.1; -; mRNA.
DR   CCDS; CCDS3216.1; -. [Q13393-1]
DR   CCDS; CCDS46957.1; -. [Q13393-2]
DR   RefSeq; NP_002653.1; NM_002662.4. [Q13393-1]
DR   RefSeq; XP_005247590.1; XM_005247533.2. [Q13393-1]
DR   RefSeq; XP_005247591.1; XM_005247534.2. [Q13393-2]
DR   RefSeq; XP_011511199.1; XM_011512897.1. [Q13393-4]
DR   UniGene; Hs.382865; -.
DR   UniGene; Hs.732969; -.
DR   ProteinModelPortal; Q13393; -.
DR   SMR; Q13393; -.
DR   BioGrid; 111353; 41.
DR   DIP; DIP-40821N; -.
DR   IntAct; Q13393; 13.
DR   MINT; MINT-141519; -.
DR   STRING; 9606.ENSP00000342793; -.
DR   BindingDB; Q13393; -.
DR   ChEMBL; CHEMBL2536; -.
DR   DrugBank; DB00122; Choline.
DR   DrugBank; DB05301; LAX-101.
DR   DrugBank; DB09031; Miltefosine.
DR   GuidetoPHARMACOLOGY; 1433; -.
DR   SwissLipids; SLP:000000149; -.
DR   iPTMnet; Q13393; -.
DR   PhosphoSitePlus; Q13393; -.
DR   SwissPalm; Q13393; -.
DR   BioMuta; PLD1; -.
DR   DMDM; 2499703; -.
DR   EPD; Q13393; -.
DR   MaxQB; Q13393; -.
DR   PaxDb; Q13393; -.
DR   PeptideAtlas; Q13393; -.
DR   PRIDE; Q13393; -.
DR   TopDownProteomics; Q13393-2; -. [Q13393-2]
DR   DNASU; 5337; -.
DR   Ensembl; ENST00000351298; ENSP00000342793; ENSG00000075651. [Q13393-1]
DR   Ensembl; ENST00000356327; ENSP00000348681; ENSG00000075651. [Q13393-2]
DR   GeneID; 5337; -.
DR   KEGG; hsa:5337; -.
DR   UCSC; uc003fhs.4; human. [Q13393-1]
DR   CTD; 5337; -.
DR   DisGeNET; 5337; -.
DR   GeneCards; PLD1; -.
DR   HGNC; HGNC:9067; PLD1.
DR   HPA; CAB004527; -.
DR   HPA; HPA042396; -.
DR   MIM; 602382; gene.
DR   neXtProt; NX_Q13393; -.
DR   OpenTargets; ENSG00000075651; -.
DR   PharmGKB; PA164742228; -.
DR   eggNOG; KOG1329; Eukaryota.
DR   eggNOG; COG1502; LUCA.
DR   GeneTree; ENSGT00390000008356; -.
DR   HOGENOM; HOG000246972; -.
DR   HOVERGEN; HBG006650; -.
DR   InParanoid; Q13393; -.
DR   KO; K01115; -.
DR   OMA; LFNCCKS; -.
DR   OrthoDB; EOG091G017Y; -.
DR   PhylomeDB; Q13393; -.
DR   TreeFam; TF300589; -.
DR   BioCyc; MetaCyc:HS01185-MONOMER; -.
DR   BRENDA; 3.1.4.4; 2681.
DR   Reactome; R-HSA-1483148; Synthesis of PG.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   Reactome; R-HSA-2029485; Role of phospholipids in phagocytosis.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; Q13393; -.
DR   SIGNOR; Q13393; -.
DR   ChiTaRS; PLD1; human.
DR   GeneWiki; Phospholipase_D1; -.
DR   GenomeRNAi; 5337; -.
DR   PRO; PR:Q13393; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000075651; -.
DR   CleanEx; HS_PLD1; -.
DR   ExpressionAtlas; Q13393; baseline and differential.
DR   Genevisible; Q13393; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030139; C:endocytic vesicle; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; IDA:MGI.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:MGI.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031902; C:late endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0070290; F:N-acylphosphatidylethanolamine-specific phospholipase D activity; IEA:UniProtKB-EC.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IEA:InterPro.
DR   GO; GO:0004630; F:phospholipase D activity; TAS:Reactome.
DR   GO; GO:0048870; P:cell motility; IBA:GO_Central.
DR   GO; GO:0006935; P:chemotaxis; TAS:ProtInc.
DR   GO; GO:0048017; P:inositol lipid-mediated signaling; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0007265; P:Ras protein signal transduction; TAS:ProtInc.
DR   GO; GO:0032534; P:regulation of microvillus assembly; IMP:UniProtKB.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.1520.10; -; 1.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR001683; Phox.
DR   InterPro; IPR025202; PLD-like_dom.
DR   InterPro; IPR001736; PLipase_D/transphosphatidylase.
DR   InterPro; IPR016555; PLipase_D1/D2.
DR   InterPro; IPR015679; PLipase_D_fam.
DR   PANTHER; PTHR18896; PTHR18896; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00614; PLDc; 1.
DR   Pfam; PF13091; PLDc_2; 1.
DR   Pfam; PF00787; PX; 1.
DR   PIRSF; PIRSF009376; Phospholipase_D_euk; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00155; PLDc; 2.
DR   SMART; SM00312; PX; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF64268; SSF64268; 1.
DR   PROSITE; PS50035; PLD; 2.
DR   PROSITE; PS50195; PX; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Endoplasmic reticulum; Endosome; Golgi apparatus; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat.
FT   CHAIN         1   1074       Phospholipase D1.
FT                                /FTId=PRO_0000218802.
FT   DOMAIN       81    212       PX. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00147}.
FT   DOMAIN      219    328       PH.
FT   DOMAIN      459    486       PLD phosphodiesterase 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00153}.
FT   DOMAIN      891    918       PLD phosphodiesterase 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00153}.
FT   REGION      463    928       Catalytic.
FT   MOD_RES     499    499       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70496}.
FT   MOD_RES     561    561       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     629    629       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:23186163}.
FT   LIPID       240    240       S-palmitoyl cysteine. {ECO:0000250}.
FT   LIPID       241    241       S-palmitoyl cysteine. {ECO:0000250}.
FT   VAR_SEQ     514    597       PAAMESMESLRLKDKNEPVQNLPIQKSIDDVDSKLKGIGKP
FT                                RKFSKFSLYKQLHRHHLHDADSISSIDSTSSYFNHYRSHHN
FT                                LI -> IPGPSVVYRQVWESCMGKPDSGMERTTAISSSKTG
FT                                FNLINLLLISLTGTPRPGCPGMTLPLQSTGRRLVMWHVTSS
FT                                SAGTSQKL (in isoform PLD1C).
FT                                {ECO:0000303|PubMed:9761774}.
FT                                /FTId=VSP_005018.
FT   VAR_SEQ     585    623       SYFNHYRSHHNLIHGLKPHFKLFHPSSESEQGLTRPHAD
FT                                -> N (in isoform PLD1B).
FT                                {ECO:0000303|PubMed:9013646,
FT                                ECO:0000303|PubMed:9761774}.
FT                                /FTId=VSP_005020.
FT   VAR_SEQ     598   1074       Missing (in isoform PLD1C).
FT                                {ECO:0000303|PubMed:9761774}.
FT                                /FTId=VSP_005019.
FT   VAR_SEQ     962    971       VVLGYLDDPS -> SKMTPGVEDP (in isoform
FT                                PLD1D). {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_005021.
FT   VAR_SEQ     972   1074       Missing (in isoform PLD1D).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_005022.
FT   VARIANT      49     49       P -> A (in dbSNP:rs9819927).
FT                                /FTId=VAR_034387.
FT   VARIANT     622    622       A -> S (in dbSNP:rs2290480).
FT                                /FTId=VAR_022056.
FT   VARIANT     820    820       V -> M (in dbSNP:rs2287579).
FT                                /FTId=VAR_022057.
FT   VARIANT    1024   1024       V -> I (in dbSNP:rs9827333).
FT                                /FTId=VAR_051703.
FT   CONFLICT    832    832       S -> P (in Ref. 3; CAB76564).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1074 AA;  124184 MW;  734F285790A0BF7A CRC64;
     MSLKNEPRVN TSALQKIAAD MSNIIENLDT RELHFEGEEV DYDVSPSDPK IQEVYIPFSA
     IYNTQGFKEP NIQTYLSGCP IKAQVLEVER FTSTTRVPSI NLYTIELTHG EFKWQVKRKF
     KHFQEFHREL LKYKAFIRIP IPTRRHTFRR QNVREEPREM PSLPRSSENM IREEQFLGRR
     KQLEDYLTKI LKMPMYRNYH ATTEFLDISQ LSFIHDLGPK GIEGMIMKRS GGHRIPGLNC
     CGQGRACYRW SKRWLIVKDS FLLYMKPDSG AIAFVLLVDK EFKIKVGKKE TETKYGIRID
     NLSRTLILKC NSYRHARWWG GAIEEFIQKH GTNFLKDHRF GSYAAIQENA LAKWYVNAKG
     YFEDVANAME EANEEIFITD WWLSPEIFLK RPVVEGNRWR LDCILKRKAQ QGVRIFIMLY
     KEVELALGIN SEYTKRTLMR LHPNIKVMRH PDHVSSTVYL WAHHEKLVII DQSVAFVGGI
     DLAYGRWDDN EHRLTDVGSV KRVTSGPSLG SLPPAAMESM ESLRLKDKNE PVQNLPIQKS
     IDDVDSKLKG IGKPRKFSKF SLYKQLHRHH LHDADSISSI DSTSSYFNHY RSHHNLIHGL
     KPHFKLFHPS SESEQGLTRP HADTGSIRSL QTGVGELHGE TRFWHGKDYC NFVFKDWVQL
     DKPFADFIDR YSTPRMPWHD IASAVHGKAA RDVARHFIQR WNFTKIMKSK YRSLSYPFLL
     PKSQTTAHEL RYQVPGSVHA NVQLLRSAAD WSAGIKYHEE SIHAAYVHVI ENSRHYIYIE
     NQFFISCADD KVVFNKIGDA IAQRILKAHR ENQKYRVYVV IPLLPGFEGD ISTGGGNALQ
     AIMHFNYRTM CRGENSILGQ LKAELGNQWI NYISFCGLRT HAELEGNLVT ELIYVHSKLL
     IADDNTVIIG SANINDRSML GKRDSEMAVI VQDTETVPSV MDGKEYQAGR FARGLRLQCF
     RVVLGYLDDP SEDIQDPVSD KFFKEVWVST AARNATIYDK VFRCLPNDEV HNLIQLRDFI
     NKPVLAKEDP IRAEEELKKI RGFLVQFPFY FLSEESLLPS VGTKEAIVPM EVWT
//
